Effect of Rasagiline in Patients With Parkinson's Disease

Study Title

ParFemale, Maleel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

Teva Identifier

TVP-1012/PM106

ClinicalTrials.gov Identifier

NCT01723228

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

45 Years to 80 Years

Trial Duration

11/01/2012 - 01/01/2015

Phase

Phase 4

Study Type

Interventional